Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00422630 · ClinicalTrials.gov registry record · NA
The Metabolic Effects of Different Weight Loss Diets
A NA study, sponsored by Rockefeller University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00422630 is a NA study that has completed, run by Rockefeller University. The registered enrollment target is 18 participants.
The verdict
NCT00422630, a NA study, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Current estimates suggest that 65% of American adults are overweight or obese. Excess body weight has been associated with an increased risk of a number of metabolic abnormalities, including high blood sugar, high blood pressure, high triglyceride levels, and low HDL ("good") cholesterol levels. Insulin resistance (when the body becomes less sensitive to the blood sugar-lowering hormone insulin, and more of the hormone is needed to keep blood sugar levels under control) also frequently occurs as a result of excess body weight. These abnormalities can all increase the risk of heart disease and other serious medical problems. Individuals who are overweight often have a number of these abnormalities at the same time, a situation which is often called "the metabolic syndrome." Dietary changes, physical activity, and weight loss can lead to improvements in each of the metabolic abnormalities described above. However, the best type of diet for people with the metabolic syndrome is not known. This study has been designed to test the effects of several promising dietary patterns, with and without weight loss, in overweight adults with the metabolic syndrome. Most individuals who have the metabolic syndrome do not know they have the condition, so we will be screening many healthy overweight volunteers to see if they may be eligible.
Interventions
- BEHAVIORAL The DASH diet
- BEHAVIORAL The low glycemic Index Diet
- BEHAVIORAL Reduced calorie American Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00422630
The ClinicalTrials.gov registry entry for NCT00422630 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which The DASH diet is the first listed.
NCT00422630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00422630 about?
NCT00422630 is a clinical study titled "The Metabolic Effects of Different Weight Loss Diets". Current estimates suggest that 65% of American adults are overweight or obese. Excess body weight has been associated with an increased risk of a number of metabolic abnormalities, including high blood sugar, high blood pressure, high triglyceride levels, and low HDL ("good") cholesterol levels. Ins...
What is the current status of trial NCT00422630?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2007-10. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00422630?
The interventions under investigation include: The DASH diet (BEHAVIORAL), The low glycemic Index Diet (BEHAVIORAL), Reduced calorie American Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00422630?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.